Nextmune Acquires VetBiotek

Vimian Group (Nextmune) Acquires GlobalOne Pet Products

December 3, 2021

Food & Beverage

Vimian Group's Specialty Pharma segment Nextmune has acquired GlobalOne Pet Products LLC, a US-based maker of super-premium, rawhide-free pet treats and chews. The deal is valued at USD 50 million plus up to USD 30 million in earnouts, and will be consolidated into Vimian's Specialty Pharma segment; GlobalOne's co-founder Michael Farmer will continue to lead the business.

DermBiont Acquires SeylanMED to Expand Dermatology Pipeline

October 21, 2020

Biotechnology

DermBiont, a Boston-based clinical-stage precision dermatology company, has acquired SeylanMED, adding a targeted topical AKT inhibitor gel candidate for seborrheic keratosis to its pipeline. The acquisition expands DermBiont's therapeutic modalities and accelerates its objective to develop targeted topical treatments and live bacterial therapeutics for skin diseases.

Dechra Pharmaceuticals to Acquire Invetx

July 18, 2024

Biotechnology

Dechra Pharmaceuticals Limited has agreed to acquire Boston-based Invetx Inc., a developer of species-specific monoclonal antibody therapeutics for companion animals, for up to $520 million on a cash-free, debt-free basis, subject to customary approvals. The deal gives Dechra access to Invetx's pipeline and half-life extension platform to expand its specialty veterinary biologics capabilities.

Swedencare Acquires Vetio Animal Health from Thompson Street Capital Partners

July 1, 2021

Veterinary

Swedencare AB has acquired Vetio Animal Health, a North American contract development and manufacturing organization (CDMO) focused on veterinary pharmaceuticals, supplements and dermatology products, from Thompson Street Capital Partners. Thompson Street supported Vetio's growth through facility expansions and the acquisition of TetraGenx; Swedencare intends to leverage Vetio's manufacturing capabilities to expand its pet healthcare product portfolio and supply capabilities in North America.

BioDerm (Mountaingate) Acquires Argentum Medical

February 1, 2023

Medical Devices

BioDerm, a portfolio company of Mountaingate Capital, has acquired Argentum Medical and combined the business with BioDerm to create a larger wound-care and infection-prevention platform. Mountaingate supported the combination through its existing ownership of BioDerm and new investment in the combined entity, with Five Points Capital providing unitranche financing to support the refinancing and acquisition; Shore Capital Partners sold Argentum.

Gryphon Investors Acquires Vetnique Labs

April 20, 2023

Consumer Products

Gryphon Investors, a San Francisco-based private equity firm, has acquired Vetnique Labs, a Naperville, Illinois-based pet health and wellness company. Gryphon will partner with founder and CEO James Bascharon (who will remain in role and retain a significant stake) to expand Vetnique’s product portfolio and geographic reach; financial terms were not disclosed.